Insys Therapeutics, Inc. (NASDAQ:INSY) Quarterly Basic Net EPS At 2016-03-31

0

For the year ended 2016-03-31 Insys Therapeutics, Inc. (NASDAQ:INSY) basic consolidated EPS came $0.8168. Conversely, for the quarter ended 2016-03-31, it was $0.8168.

EPS can be simply called as a fraction of profits that is disbursed against each outstanding share. It is measured using the formula – net profit/outstanding shares. The element ‘Per-share earnings’ is majorly utilized by market experts to give earnings and price projections. Suppose a group “S” announces a net profit of $15,000 in a given year. The count of outstanding shares is 300. So, its EPS will be $50. EPS is issued every quarter, indicating the stakeholders can evaluate the financial performance periodically.

EPS alone cannot indicate on the financial well-being of a firm. For a clear picture, it is vital to look into the price to earnings ratio of company.

EPS from continuing operations

Insys Therapeutics, Inc. (NASDAQ:INSY) EPS from continuing operations was $0.8168 for the fiscal ended 2016-03-31. For the quarter ended 2016-03-31, this figure was $0.8168.

EPS contribution from parent

Insys Therapeutics, Inc. (NASDAQ:INSY) confirmed basic EPS of $0.8168 for the year ended 2016-03-31 from its parent group. Conversely, for the quarter closed 2016-03-31 it was $0.8168.

Basic net EPS

Insys Therapeutics, Inc. (NASDAQ:INSY) basic net EPS was $0.03 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it came at $0.03.

Consolidated diluted EPS

Insys Therapeutics, Inc. (NASDAQ:INSY) consolidated diluted EPS was 0.7724 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it stood at $0.7724.

Basic diluted EPS

Insys Therapeutics, Inc. (NASDAQ:INSY) basic diluted EPS was $0.0327 for the quarter ended 2016-03-31. For the year ended 2016-03-31, basic diluted EPS was $0.0327.

Net diluted EPS

Insys Therapeutics, Inc. (NASDAQ:INSY) posted net diluted EPS of $0.77 for the fiscal closed 2016-03-31. For the quarter ended 2016-03-31, net diluted EPS was $0.77.

Diluted EPS from parent

Insys Therapeutics, Inc. (NASDAQ:INSY) diluted EPS from parent group was $0.7724 for the year ended 2016-03-31. For the quarter ended 2016-03-31 it stood at $0.7724.

Insys Therapeutics, Inc. (NASDAQ:INSY) net basic EPS was $0.55 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it was $0.55.

For the year ended 2016-03-31, basic shares outstanding were 68.76 while for the quarter ended 2016-03-31 is 68.76.

For the fiscal ended 2016-03-31, the diluted outstanding shares were 73.336 and for the quarter ended 2016-03-31 it was 73.336.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 1 times, 1 visits today)